Axsome to Present Findings on Solriamfetol's Cognitive Benef

Axsome will unveil data demonstrating solriamfetol's ability to enhance cognitive functioning in patients with OSA and narcolepsy.

Related Keywords

Germany , Herdecke , Nordrhein Westfalen , Johannes Gutenberg , Michael Thorpy , Solriamfetol Sunosi , Ulf Kallweit , Hans Van Dongen , Samantha Floam , Washington State University , Montefiore Medical Center , Wake Disorders Center , Department Of Neurology , Axsome Therapeutics Inc , Medicine Center , University Witten Herdecke , Axsome Therapeutics , Therapeutics Inc , Washington State , Yaroslav Winter , Mainz Comprehensive Epilepsy , Sleep Medicine Center , Johannes Gutenberg University , Sleep Wake Disorders Center , Albert Einstein College ,